Matches in Nanopublications for { <http://bio2rdf.org/drugbank:DB05159> ?p ?o ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05159 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05159 label "CCX915 [drugbank:DB05159]" assertion.
- drugbank:DB05159 seeAlso DB05159 assertion.
- drugbank:DB05159 identifier "drugbank:DB05159" assertion.
- drugbank:DB05159 description "CCX915 is developed by ChemoCentryx which targets the chemokine receptor CCR2 and is in phase 1 of clinical trial for the treatment of Multiple Sclerosis and Neurologic Disorders. The CCR2 receptor is thought to be of central importance to inflammatory diseases, such as multiple sclerosis (MS), Type II diabetes and atherosclerosis." assertion.
- drugbank:DB05159 title "CCX915" assertion.
- drugbank:DB05159 bio2rdf_vocabulary:identifier "DB05159" assertion.
- drugbank:DB05159 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05159 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05159" assertion.
- drugbank:DB05159 bio2rdf_vocabulary:x-identifiers.org DB05159 assertion.
- drugbank:DB05159 drugbank_vocabulary:drugbank-id "DB05159" assertion.
- drugbank:DB05159 drugbank_vocabulary:x-cas cas: assertion.